Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic Implications

Project title

探討免疫檢查點抑制劑(促進性抗CD40抗體/ CD40配體)在肝細胞癌的免疫調節作用：治療學意義之探討

Internal ID

109-2314-B-002-229-MY3

Principal Investigator

Start Date

August 1, 2022

End Date

July 31, 2023

Organizations

Partner Organizations

National Science and Technology Council